Insiders Updates CLRB’s short interest reaches 0.14 million shares on 2025-07-31 The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Cellectar Biosciences Inc’s latest rating changes from various analysts Cellectar Biosciences Inc’s filing revealed that its Chief Operating Officer Longcor Jarrod acquired Company’s shares for reported $8400.0 on Jan
Analysts Viewpoint Chief Operating Officer Longcor Jarrod acquired 30,000 shares of Cellectar Biosciences Inc [CLRB] The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or